A Houston hospital has halted its liver and kidney transplant programs after it says a doctor manipulated a database for liver transplant patients, making them ineligible to receive a new organ.
Apr 12, 2024
0
0
Patients hurl verbal abuse at Michelle Ravera every day in the emergency room. Physical violence is less common, she said, but has become a growing threat.
Apr 11, 2024
0
0
French pharmaceutical giant Sanofi said Thursday it had reached a preliminary agreement on settling thousands of US lawsuits concerning its heartburn drug Zantac.
Apr 4, 2024
0
0
Russian intelligence has been linked to mysterious so-called Havana Syndrome symptoms experienced by US diplomats, a media investigation said Monday, but the State Department stood by its assessment that no foreign actor ...
Apr 1, 2024
0
3
More than half of all new doctors face some form of sexual harassment in their first year on the job, including nearly three-quarters of all new female doctors and a third of males, a new study finds.
Mar 22, 2024
0
43
Endogenous opioid peptides are the neurochemical basis of the anesthetic and analgesic effects of acupuncture. The quantity of acupuncture stimulus can be controlled accurately by using electroacupuncture.
Mar 21, 2024
0
3
Biomedical programs in the United States attract a significant number of graduate and postdoctoral trainees from around the world. Non-citizen trainees face several systemic barriers that negatively affect their confidence ...
Mar 21, 2024
0
0
Findings from a study led by researchers at the Florence Nightingale Faculty of Nursing, Midwifery & Palliative Care have identified four key themes relating to the implementation and ethical use of body-worn cameras in mental ...
Mar 20, 2024
0
0
Following a cyberattack on one of the nation's largest health insurers that's thrown health care payments into disarray and likely exposed reams of private patient data, the U.S. Department of Health and Human Services said ...
Mar 14, 2024
0
0
Anglo-Swedish pharmaceuticals giant AstraZeneca on Thursday agreed to buy French biotech specialist Amolyt Pharma for about $1 billion, expanding further into the field of rare drugs.
Mar 14, 2024
0
0
